Annual CFO
-$18.73 M
-$3.90 M-26.32%
December 31, 2023
Summary
- As of February 8, 2025, XBIT annual cash flow from operations is -$18.73 million, with the most recent change of -$3.90 million (-26.32%) on December 31, 2023.
- During the last 3 years, XBIT annual CFO has risen by +$46.42 million (+71.26%).
- XBIT annual CFO is now -126.96% below its all-time high of $69.44 million, reached on December 31, 2021.
Performance
XBIT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$5.84 M
+$5.53 M+48.62%
September 30, 2024
Summary
- As of February 8, 2025, XBIT quarterly cash flow from operations is -$5.84 million, with the most recent change of +$5.53 million (+48.62%) on September 30, 2024.
- Over the past year, XBIT quarterly CFO has dropped by -$4.36 million (-293.07%).
- XBIT quarterly CFO is now -108.03% below its all-time high of $72.80 million, reached on June 30, 2021.
Performance
XBIT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$27.86 M
-$4.36 M-18.55%
September 30, 2024
Summary
- As of February 8, 2025, XBIT TTM cash flow from operations is -$27.86 million, with the most recent change of -$4.36 million (-18.55%) on September 30, 2024.
- Over the past year, XBIT TTM CFO has dropped by -$9.40 million (-50.93%).
- XBIT TTM CFO is now -134.10% below its all-time high of $81.70 million, reached on June 30, 2021.
Performance
XBIT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
XBIT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.3% | -293.1% | -50.9% |
| 3 y3 years | +71.3% | -71.8% | -139.3% |
| 5 y5 years | -13.2% | -17.3% | -52.5% |
XBIT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -127.0% | at low | -408.3% | +48.6% | -140.1% | at low |
| 5 y | 5-year | -127.0% | +71.3% | -108.0% | +90.4% | -134.1% | +65.6% |
| alltime | all time | -127.0% | +71.3% | -108.0% | +90.4% | -134.1% | +65.6% |
XBiotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.84 M(-48.6%) | -$27.86 M(+18.5%) |
| Jun 2024 | - | -$11.38 M(+58.0%) | -$23.50 M(+11.3%) |
| Mar 2024 | - | -$7.20 M(+109.8%) | -$21.12 M(+12.8%) |
| Dec 2023 | -$18.73 M(+26.3%) | -$3.43 M(+130.9%) | -$18.73 M(+1.5%) |
| Sep 2023 | - | -$1.49 M(-83.5%) | -$18.46 M(+1.9%) |
| Jun 2023 | - | -$9.00 M(+87.1%) | -$18.12 M(+24.9%) |
| Mar 2023 | - | -$4.81 M(+52.0%) | -$14.51 M(-2.1%) |
| Dec 2022 | -$14.82 M(-121.3%) | -$3.16 M(+175.1%) | -$14.82 M(+10.5%) |
| Sep 2022 | - | -$1.15 M(-78.7%) | -$13.42 M(-14.4%) |
| Jun 2022 | - | -$5.39 M(+5.2%) | -$15.67 M(-125.1%) |
| Mar 2022 | - | -$5.12 M(+191.2%) | $62.51 M(-10.0%) |
| Dec 2021 | $69.44 M(-206.6%) | -$1.76 M(-48.3%) | $69.44 M(-1.9%) |
| Sep 2021 | - | -$3.40 M(-104.7%) | $70.81 M(-13.3%) |
| Jun 2021 | - | $72.80 M(+3924.2%) | $81.70 M(-3163.3%) |
| Mar 2021 | - | $1.81 M(-562.7%) | -$2.67 M(-95.9%) |
| Dec 2020 | -$65.15 M(+256.6%) | -$391.00 K(-105.2%) | -$65.15 M(-4.9%) |
| Sep 2020 | - | $7.48 M(-164.7%) | -$68.50 M(-15.4%) |
| Jun 2020 | - | -$11.57 M(-80.9%) | -$80.97 M(+9.0%) |
| Mar 2020 | - | -$60.67 M(+1519.7%) | -$74.27 M(+306.5%) |
| Dec 2019 | -$18.27 M | -$3.75 M(-24.8%) | -$18.27 M(-7.0%) |
| Sep 2019 | - | -$4.98 M(+2.5%) | -$19.64 M(+5.3%) |
| Jun 2019 | - | -$4.86 M(+4.0%) | -$18.65 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$4.68 M(-8.6%) | -$17.69 M(+7.0%) |
| Dec 2018 | -$16.54 M(-50.9%) | -$5.12 M(+28.1%) | -$16.54 M(-9.3%) |
| Sep 2018 | - | -$4.00 M(+2.4%) | -$18.23 M(-11.9%) |
| Jun 2018 | - | -$3.90 M(+10.6%) | -$20.70 M(-18.1%) |
| Mar 2018 | - | -$3.53 M(-48.2%) | -$25.27 M(-24.9%) |
| Dec 2017 | -$33.65 M(-26.9%) | -$6.81 M(+5.3%) | -$33.65 M(-15.1%) |
| Sep 2017 | - | -$6.47 M(-23.6%) | -$39.64 M(-17.7%) |
| Jun 2017 | - | -$8.47 M(-28.9%) | -$48.19 M(+0.5%) |
| Mar 2017 | - | -$11.91 M(-7.0%) | -$47.98 M(+4.3%) |
| Dec 2016 | -$46.02 M(+38.1%) | -$12.80 M(-14.8%) | -$46.02 M(+4.8%) |
| Sep 2016 | - | -$15.02 M(+82.0%) | -$43.91 M(+21.6%) |
| Jun 2016 | - | -$8.25 M(-17.1%) | -$36.11 M(-1.7%) |
| Mar 2016 | - | -$9.95 M(-7.0%) | -$36.72 M(+10.3%) |
| Dec 2015 | -$33.31 M(+184.7%) | -$10.70 M(+48.2%) | -$33.31 M(+27.8%) |
| Sep 2015 | - | -$7.22 M(-18.5%) | -$26.06 M(+18.1%) |
| Jun 2015 | - | -$8.86 M(+35.7%) | -$22.07 M(+38.9%) |
| Mar 2015 | - | -$6.53 M(+89.2%) | -$15.89 M(+35.8%) |
| Dec 2014 | -$11.70 M(+31.3%) | -$3.45 M(+6.9%) | -$11.70 M(+41.8%) |
| Sep 2014 | - | -$3.23 M(+20.4%) | -$8.25 M(+64.3%) |
| Jun 2014 | - | -$2.68 M(+14.6%) | -$5.02 M(+114.6%) |
| Mar 2014 | - | -$2.34 M | -$2.34 M |
| Dec 2013 | -$8.91 M(-23.4%) | - | - |
| Dec 2012 | -$11.63 M | - | - |
FAQ
- What is XBiotech annual cash flow from operations?
- What is the all time high annual CFO for XBiotech?
- What is XBiotech annual CFO year-on-year change?
- What is XBiotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for XBiotech?
- What is XBiotech quarterly CFO year-on-year change?
- What is XBiotech TTM cash flow from operations?
- What is the all time high TTM CFO for XBiotech?
- What is XBiotech TTM CFO year-on-year change?
What is XBiotech annual cash flow from operations?
The current annual CFO of XBIT is -$18.73 M
What is the all time high annual CFO for XBiotech?
XBiotech all-time high annual cash flow from operations is $69.44 M
What is XBiotech annual CFO year-on-year change?
Over the past year, XBIT annual cash flow from operations has changed by -$3.90 M (-26.32%)
What is XBiotech quarterly cash flow from operations?
The current quarterly CFO of XBIT is -$5.84 M
What is the all time high quarterly CFO for XBiotech?
XBiotech all-time high quarterly cash flow from operations is $72.80 M
What is XBiotech quarterly CFO year-on-year change?
Over the past year, XBIT quarterly cash flow from operations has changed by -$4.36 M (-293.07%)
What is XBiotech TTM cash flow from operations?
The current TTM CFO of XBIT is -$27.86 M
What is the all time high TTM CFO for XBiotech?
XBiotech all-time high TTM cash flow from operations is $81.70 M
What is XBiotech TTM CFO year-on-year change?
Over the past year, XBIT TTM cash flow from operations has changed by -$9.40 M (-50.93%)